Literature DB >> 12810820

PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma.

Sarah Siggins1, Matti Jauhiainen, Vesa M Olkkonen, Jukka Tenhunen, Christian Ehnholm.   

Abstract

Plasma phospholipid transfer protein (PLTP) is an important regulator of plasma HDL levels and HDL particle distribution. PLTP is present in plasma in two forms, one with high and the other with low phospholipid transfer activity. We have used the human hepatoma cell line, HepG2, as a model to study PLTP secreted from hepatic cells. PLTP activity was secreted by the cells into serum-free culture medium as a function of time. However, modification of a previously established ELISA assay to include a denaturing sample pretreatment with the anionic detergent sodium dodecyl sulphate was required for the detection of the secreted PLTP protein. The HepG2 PLTP could be enriched by Heparin-Sepharose affinity chromatography and eluted in size-exclusion chromatography at a position corresponding to the size of 160 kDa. PLTP coeluted with apolipoprotein E (apoE) but not with apoB-100 or apoA-I. A portion of PLTP was retained by an anti-apoE immunoaffinity column together with apoE, suggesting an interaction between these two proteins. Furthermore, antibodies against apoE but not those against apoB-100 or apoA-I were capable of inhibiting PLTP activity. These results show that the HepG2-derived PLTP resembles in several aspects the high-activity form of PLTP found in human plasma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810820     DOI: 10.1194/jlr.M300059-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  16 in total

1.  Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein.

Authors:  John J Albers; Joseph R Day; Gertrud Wolfbauer; Hal Kennedy; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-04-16

2.  Dry eye symptoms are increased in mice deficient in phospholipid transfer protein (PLTP).

Authors:  Niko L Setälä; Jari Metso; Matti Jauhiainen; Antti Sajantila; Juha M Holopainen
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

Authors:  Baiba K Gillard; Hu-Yu Alice Lin; John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2009-07-25

Review 4.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

5.  Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.

Authors:  Su Duy Nguyen; Katariina Öörni; Miriam Lee-Rueckert; Tero Pihlajamaa; Jari Metso; Matti Jauhiainen; Petri T Kovanen
Journal:  J Lipid Res       Date:  2012-08-01       Impact factor: 5.922

6.  Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.

Authors:  Laxman Yetukuri; Sanni Söderlund; Artturi Koivuniemi; Tuulikki Seppänen-Laakso; Perttu S Niemelä; Marja Hyvönen; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Oresic
Journal:  J Lipid Res       Date:  2010-04-29       Impact factor: 5.922

7.  Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles.

Authors:  Karita Haapasalo; Kok van Kessel; Eija Nissilä; Jari Metso; Tiira Johansson; Sini Miettinen; Markku Varjosalo; Juha Kirveskari; Pentti Kuusela; Angelika Chroni; Matti Jauhiainen; Jos van Strijp; T Sakari Jokiranta
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

8.  Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity.

Authors:  Marian C Cheung; Gertrud Wolfbauer; John J Albers
Journal:  Biochim Biophys Acta       Date:  2011-02-16

9.  Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass.

Authors:  Marius R Robciuc; Jari Metso; Anca Sima; Christian Ehnholm; Matti Jauhiainen
Journal:  Lipids Health Dis       Date:  2010-06-09       Impact factor: 3.876

10.  Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages.

Authors:  Aino Salminen; Pirkko J Pussinen; Jeffrey B Payne; Julie A Stoner; Matti Jauhiainen; Lorne M Golub; Hsi-Ming Lee; David M Thompson; Timo Sorsa
Journal:  Inflamm Res       Date:  2013-05-07       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.